These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1259465)

  • 1. [Reflexphotometric determinations of vasoconstriction after topical application of steroids. IV. Time slope of vasoconstriction and reactive vasodilatation (author's transl)].
    Altmeyer P; Zaun H
    Arch Dermatol Res (1975); 1976 Mar; 255(1):43-50. PubMed ID: 1259465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Reflexphotometric determinations of vasoconstriction after topical application of steroids. V. Vasoconstriction phaenomenon and tachyphylaxis after repeated steroid application (author's transl)].
    Altmeyer P; Zaun H
    Arch Dermatol Res (1975); 1976 Mar; 255(1):51-6. PubMed ID: 1259466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reflexphotometric determinations of vasoconstriction after topical application of steroids. Method, reliability, errors (author's transl)].
    Zaun H; Altmeyer P
    Arch Dermatol Forsch; 1973; 247(4):379-86. PubMed ID: 4767633
    [No Abstract]   [Full Text] [Related]  

  • 4. [The cutaneous vasoconstriction test in man as a means of evaluating topical corticoids. II. Cutaneous vasoconstrictive effects of topical corticoids in tests devised by various investigators (author's transl)].
    Lutz U; Weirich EG
    Dermatologica; 1974; 148(3):160-74. PubMed ID: 4836957
    [No Abstract]   [Full Text] [Related]  

  • 5. Results of reflex photometric determinations of vasoconstriction after topical steroid application. Tachyphylaxis, relative and absolute refractory phase after single and multiple application of steroid.
    Altmeyer P; Cremer C
    Arch Dermatol Res (1975); 1977 Jan; 257(3):281-5. PubMed ID: 836076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Reflexphotometric determinations of vasoconstriction after topical application of steroids. III. Vasoeffect of mineralocorticoids time slope of vasoconstriction influence of steroid concentration].
    Altmeyer P; Zaun H
    Arch Dermatol Forsch; 1974; 250(4):381-8. PubMed ID: 4447379
    [No Abstract]   [Full Text] [Related]  

  • 7. [An optoelectronic method for the evaluation of the cutaneous vasoconstriction and vasodilatation after topical application of different ointments (author's transl)].
    Blazek V; Wienert V
    Biomed Tech (Berl); 1980 Oct; 25(10):261-8. PubMed ID: 7448297
    [No Abstract]   [Full Text] [Related]  

  • 8. [Reflexphotometric determinations of vasoconstriction after topical application of steroids. II. Influence of solvents (author's transl)].
    Altmeyer P; Zaun H
    Arch Dermatol Forsch; 1974 Feb; 248(4):387-90. PubMed ID: 4834644
    [No Abstract]   [Full Text] [Related]  

  • 9. Glucocorticoid-induced vasoconstriction in human skin. An inhibitory role on phospholipase A2 activity.
    Marks R; Sawyer M
    Arch Dermatol; 1986 Aug; 122(8):881-3. PubMed ID: 2874773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paired comparison vasoconstrictor assays. A comparison of methods for the determination of relative vasoconstrictor potency of topically applied corticosteroids.
    Poulsen BJ; Burdick K; Bessler S
    Arch Dermatol; 1974 Mar; 109(3):367-71. PubMed ID: 4814938
    [No Abstract]   [Full Text] [Related]  

  • 11. Reflectance spectrophotometric quantification of skin colour changes induced by topical corticosteroid preparations.
    Feather JW; Ryatt KS; Dawson JB; Cotterill JA; Barker DJ; Ellis DJ
    Br J Dermatol; 1982 Apr; 106(4):437-43. PubMed ID: 7073967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative potencies of topical steroids.
    Gibson JR; Kirsch JM
    Br J Dermatol; 1986 May; 114(5):638-9. PubMed ID: 3718856
    [No Abstract]   [Full Text] [Related]  

  • 13. [Skin vasoconstriction assay in the evaluation of topical corticosteroids in man. General problems and results obtained in a series of tests (author's transl)].
    Weirich EG; Lutz U
    Dermatologica; 1973; 147(6):353-75. PubMed ID: 4788215
    [No Abstract]   [Full Text] [Related]  

  • 14. Potency assessment of topical corticoids in the vasoconstrictor assay and on tuberculin-induced inflammation.
    Schalla W; Schorning S
    Skin Pharmacol; 1991; 4(3):191-204. PubMed ID: 1768431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-frequency ultrasound sonophoresis to increase the efficiency of topical steroids: a pilot randomized study of humans.
    Maruani A; Boucaud A; Perrodeau E; Gendre D; Giraudeau B; Machet L
    Int J Pharm; 2010 Aug; 395(1-2):84-90. PubMed ID: 20472045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticosteroid-induced vasoconstriction studied by xenon 133 clearance.
    Greeson TP; Levan NE; Freedman RI; Wong WH
    J Invest Dermatol; 1973 Oct; 61(4):242-4. PubMed ID: 4744028
    [No Abstract]   [Full Text] [Related]  

  • 17. [Physiopathology of acetylcholine delayed blanch in atopics. Thermographic study (author's transl)].
    Grosshans E; Selig D; Quenneville Y; Gautherie M
    Ann Dermatol Venereol; 1977; 104(6-7):453-57. PubMed ID: 921179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical retinoic acid does not alter the vasoconstrictive properties of topical corticosteroids in humans.
    Schmied C; Saurat JH
    Dermatologica; 1991; 182(2):107-11. PubMed ID: 2050230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An attempt to evaluate the relative clinical potencies of various diluted and undiluted proprietary corticosteroid preparations.
    Gibson JR; Kirsch J; Darley CR; Burke CA
    Clin Exp Dermatol; 1983 Sep; 8(5):489-93. PubMed ID: 6641007
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of prostaglandin release by antiinflammatory steroids.
    Lewis GP; Piper PJ
    Adv Prostaglandin Thromboxane Res; 1976; 1():121-4. PubMed ID: 187032
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.